Urch CE, Suzuki R (2008). "Pathophysiology of somatic, visceral, and neuropathic cancer pain". In Sykes N, Bennett MI, Yuan CS (eds.). Clinical pain management: Cancer pain (2nd ed.). London: Hodder Arnold. pp. 3–12. ISBN978-0-340-94007-5.
Higginson IJ, Murtagh F (2010). "Cancer pain epidemiology". In Bruera ED, Portenoy RK (eds.). Cancer Pain. Cambridge University Press. p. 45. ISBN978-0-511-64048-3.
Portenoy RK, Conn M (23 June 2003). "Cancer pain syndromes". In Bruera ED, Portenoy RK (eds.). Cancer Pain: Assessment and Management. Cambridge University Press. p. 8. ISBN978-0-521-77332-4.
Gundamraj NR, Richmeimer S (January 2010). "Chest Wall Pain". In Fishman SM, Ballantyne JC, Rathmell JP (eds.). Bonica's Management of Pain. Lippincott Williams & Wilkins. pp. 1045–. ISBN978-0-7817-6827-6. Retrieved 10 June 2013.
Kurita GP, Ulrich A, Jensen TS, Werner MU, Sjøgren P (January 2012). "How is neuropathic cancer pain assessed in randomised controlled trials?". Pain. 153 (1): 13–17. doi:10.1016/j.pain.2011.08.013. PMID21903329. S2CID38733839.
Rosenstiel AK, Keefe FJ (September 1983). "The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment". Pain. 17 (1): 33–44. doi:10.1016/0304-3959(83)90125-2. PMID6226916. S2CID21533907.
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. (February 2012). "Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC". The Lancet. Oncology. 13 (2): e58 –e68. doi:10.1016/S1470-2045(12)70040-2. PMID22300860.
Atallah JN (2011). "Management of cancer pain". In Vadivelu N, Urman RD, Hines RL (eds.). Essentials of pain management. New York: Springer. pp. 597–628. doi:10.1007/978-0-387-87579-8. ISBN978-0-387-87578-1.
Kurita GP, Ulrich A, Jensen TS, Werner MU, Sjøgren P (January 2012). "How is neuropathic cancer pain assessed in randomised controlled trials?". Pain. 153 (1): 13–17. doi:10.1016/j.pain.2011.08.013. PMID21903329. S2CID38733839.
Bruera E, MacDonald N (May 1986). "Intractable pain in patients with advanced head and neck tumors: a possible role of local infection". Cancer Treatment Reports. 70 (5): 691–692. PMID3708626.
Rosenstiel AK, Keefe FJ (September 1983). "The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment". Pain. 17 (1): 33–44. doi:10.1016/0304-3959(83)90125-2. PMID6226916. S2CID21533907.
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. (February 2012). "Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC". The Lancet. Oncology. 13 (2): e58 –e68. doi:10.1016/S1470-2045(12)70040-2. PMID22300860.
Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, et al. (2005). "Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices". The Journal of Supportive Oncology. 3 (6): 399–408. PMID16350425.
Kurita GP, Ulrich A, Jensen TS, Werner MU, Sjøgren P (January 2012). "How is neuropathic cancer pain assessed in randomised controlled trials?". Pain. 153 (1): 13–17. doi:10.1016/j.pain.2011.08.013. PMID21903329. S2CID38733839.
Rosenstiel AK, Keefe FJ (September 1983). "The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment". Pain. 17 (1): 33–44. doi:10.1016/0304-3959(83)90125-2. PMID6226916. S2CID21533907.